Accessibility Menu
Rafina Innovations logo

Rafina Innovations(OTC) VICA

Market Cap$15.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-100%
5 Year-98%
1 Year+900%
1 Month+0%
$0.00
+0.00%
+0.00Today
Rafina Innovations last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-30
Rafina Innovations stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-21
1 month+0%USD 0.002026-06-22
3 month+42.86%USD 0.002026-04-28
Year to date+233.33%USD 0.002025-12-31
1 year+900%USD 0.002025-07-30
3 year+150%USD 0.002023-07-31
5 year-98.37%USD 0.062021-07-30
Since inception-99.95%USD 2.002013-10-23

Rafina Innovations Financials at a Glance

Market Cap

$15.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.26M

Net Income (TTM)

-$365.49K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-2.48 (Low)

Price

$0.00

Volume

203

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

VICA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rafina Innovations

Rafina Innovations Inc. is a pioneering company in the medical technology sector, focusing on the development, commercialization, and marketing of innovative medical devices. The company operates through two primary divisions: Clinic and Technology, providing specialized rehabilitation services and cutting-edge medical solutions across Southern Europe, the Middle East, and North Africa.

Products and Services
  • Specialized rehabilitation clinics for prosthetics and orthotics
  • Innovative medical devices and technologies for diabetic foot care
  • Licensing of proprietary technological advancements in medical fields
Growth Outlook
  • Expansion into new markets in Southern Europe and North Africa
  • Increased demand for rehabilitation services and medical devices
  • Focus on innovative solutions in bioengineering and robotic surgery
Financial Highlights
  • Recent quarterly revenue of $0, indicating a need for strategic growth
  • Trailing twelve months (TTM) net income margin of -26.9%, highlighting operational challenges
  • Current ratio of 1.18, suggesting adequate short-term financial health
Rafina Innovations Inc. has established itself as a key player in the medical technology industry, with a strong focus on rehabilitation and innovative medical solutions. The company’s Clinic division provides essential services for patients requiring prosthetics and orthotics, while the Technology division is dedicated to developing advanced medical devices. Despite facing financial challenges, including a recent quarterly revenue of $0 and a negative net income margin, the company maintains a current ratio of 1.18, indicating a solid short-term financial position. The growth outlook remains promising, with plans to expand into new markets and an increasing demand for rehabilitation services. The focus on innovative solutions in bioengineering and robotic surgery positions Rafina Innovations Inc. to capitalize on emerging trends in the healthcare sector. As the company continues to navigate its operational challenges, its commitment to advancing medical technology and improving patient care remains a core objective.
AI Generated • Jul 23, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Constantinos Zertalis

Website

www.rafina-innovations.com

Headquarters

Glasgow, NI G51 1HJ, GB

VICA Financials

Key Financial Metrics (TTM)

Gross Margin

-5.17%

Operating Margin

-26.61%

Net Income Margin

-26.95%

Return on Equity

-55.48%

Return on Capital

-19.86%

Return on Assets

-11.40%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

15.72M

Volume

203

Avg. Volume

36.03K

Financials (TTM)

Gross Profit

-$158.99K

Operating Income

-$360.96K

EBITDA

-$328.49K

Operating Cash Flow

-$1.73M

Capital Expenditure

-$8.07M

Free Cash Flow

-$9.80M

Cash & ST Invst.

$15.85K

Total Debt

$332.95K

Rafina Innovations Performance Analysis

Rafina Innovations annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 3,262,965N/A
Rafina Innovations sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32021-09-3061.6%
Q42021-12-31-100.0%
Q12022-03-31N/A
Q22022-06-30N/A
Rafina Innovations annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.01N/A
Rafina Innovations sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32021-09-30-1450.0%
Q42021-12-3199.5%
Q12022-03-31-6.4%
Q22022-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$639.00

+93.7%

Gross Margin

0.00%

N/A

Market Cap

$15.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.93K

N/A

Employees

4

N/A

Net Income

-$2.07K

+99.6%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name
Q1 2022YOY CHG

Total Cash

$15.85K

-2.4%

Total Debt

$332.95K

-41.9%

Accounts Receivable

$3.86M

-5.3%

Inventory

$0.00

N/A

Long Term Debt

$332.95K

-41.9%

Short Term Debt

$0.00

N/A

Return on Assets

-11.40%

N/A

Return on Invested Capital

-19.64%

N/A

Free Cash Flow

-$8.08M

-1569461.9%

Operating Cash Flow

-$13.25K

-2473.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REMIRemedent, Inc.
$0.00+0.00%
LCDXCaliber Imaging & Diagnostics, Inc.
$0.00+0.00%
IVBTInnovation1 Biotech Inc.
$0.00+0.00%
BXRXQBaudax Bio, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About VICA

What is the current price of Rafina Innovations?

Rafina Innovations is trading at $0.00 per share.

What is the 52-week range for Rafina Innovations?

Over the past 52 weeks, Rafina Innovations has traded between $0.00 and $0.00.

How much debt does Rafina Innovations have?

As of the most recent reporting period, Rafina Innovations reported total debt of $333.07K.

How much cash does Rafina Innovations have on hand?

Rafina Innovations reported $15.85K in cash and cash equivalents in its most recent financial results.

What is Rafina Innovations’s dividend yield?

Rafina Innovations does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services